Check-Cap Ltd. (MBAI)
NASDAQ: MBAI · Real-Time Price · USD
1.820
+0.020 (1.11%)
At close: Apr 2, 2026, 4:00 PM EDT
1.890
+0.070 (3.85%)
After-hours: Apr 2, 2026, 7:57 PM EDT
Check-Cap Market Cap
Check-Cap has a market cap or net worth of $13.26 million as of April 2, 2026. Its market cap has increased by 210.56% in one year.
Market Cap
13.26M
Enterprise Value
11.99M
1-Year Change
210.56%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since March 19, 2015, Check-Cap's market cap has decreased from $58.80M to $13.26M, a decrease of -77.44%. That is a compound annual growth rate of -12.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 13.26M | 33.82% |
| Dec 31, 2025 | 9.91M | 71.14% |
| Dec 31, 2024 | 5.79M | -52.40% |
| Dec 29, 2023 | 12.17M | -5.04% |
| Dec 30, 2022 | 12.81M | -80.30% |
| Dec 31, 2021 | 65.04M | 205.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FONAR | 121.87M |
| Insight Molecular Diagnostics | 120.95M |
| MDxHealth | 110.95M |
| Exagen | 73.60M |
| Precipio | 45.59M |
| bioAffinity Technologies | 17.62M |
| Inotiv | 9.18M |
| Advanced Biomed | 6.21M |